Cancer Institute A national cancer institute
designated cancer center

Ginna G. Laport

Publication Details

  • Peripheral T-cell lymphoma: autologous hematopoietic cell transplantation as first-line therapy.

    Laport GG, Curr Opin Oncol. 2010; 22 (5): 409-13

    The peripheral T-cell lymphomas (PTCL) are a heterogeneous group of non-Hodgkin's lymphomas associated with an unfavorable prognosis compared with the B-cell non-Hodgkin's lymphomas. The PTCLs are characterized by high remission rates after frontline therapy, but relapse inevitably occurs. The impact of high-dose chemotherapy with autologous hematopoietic cell transplantation (AHCT) as early consolidation therapy will be the focus of this review.

    PubMedID: 20683269

Stanford Medicine Resources:

Footer Links: